July 21, 2005 – Two companies are collaborating on a research program to develop biosensors using technology involved with enzyme coated carbon nanotubes, according to PrimeZone.
Nano-Proprietary Inc. through its subsidiary, Applied Nanotech, Inc., and Funai Electric Advanced Applied Technology Research Institute, a subsidiary of Funai Electric, Ltd., will make it the ultimate goal of this program, which will take place in phases, to develop nanobiosensor products for use in the health care field to perform testing procedures using electronic semiconductor chips. These applications are commonly referred to as lab-on-chip applications. The first phase, which will generate nominal revenue for ANI, will span approximately four months, beginning August 1.
“We are pleased that Funai Technology Research Institute has recognized the importance of our enzyme coated carbon nanotubes for a new family of sensor devices,” said Dr. Zvi Yaniv, CEO of Applied Nanotech, Inc. “Enzyme coated carbon nanotubes allow for enhanced sensitivity and selectivity and have the potential to eliminate false positives.”